Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1380-1387

  Lindley, Celeste ^a   Vasa, Shamul ^a   Sawyer, William T ^a   Winer, Eric P ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; FATIGUE; HUMAN; MAJOR CLINICAL STUDY; PARESTHESIA; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SEXUAL DYSFUNCTION; TREATMENT OUTCOME;

EID: 0031900550     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1380     Document Type: Article

References (31)

1. Kiebert GM, de Haes JCJM, van de Velde CJH: The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: A review. J Clin Oncol 9:1059-1070, 1991
2. Maguire GP, Lee EG, Bebington DJ, et al: Psychiatric problems in the first year after mastectomy. Br Med J 1:965-965, 1978
3. Silbergfarb PM, Maurer H, Vrouthamel CS: Psychosocial aspects of neoplastic disease: I. Functional status of breast cancer patients during different treatment regimens. Am J Psychiatr 173:450-455, 1980
4. Maguire GP, Tait A, Brooke M, et al: Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J 281:1179-1180, 1988
5. Cooper AF, Hughson AV, McArdle CS, et al: Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy. Br Med J 281:1641, 1980
6. Meyerowitz BE, Watkins IK, Sparks FC: Quality of life for breast cancer patients receiving adjuvant chemotherapy. Am J Nurs 83:232-235, 1983
7. Palmer BV, Walsh GA, McKinna JA, et al: Adjuvant chemotherapy for breast cancer: Side effects and quality of life. Br Med J 281:1594-1597, 1980
8. Torrance GW: Preferences for health states: A review of measurement methods, in Sinclair JC (ed): Clinical and Economic Evaluation of Perinatal Programs. Mead Johnson Symposium on Perinatal and Developmental Medicine, 1982, p 37
9. O'Connor AM: Effects of framing and level of probability on patients' preferences for cancer chemotherapy. J Clin Epidemiol 42:119-126, 1989
10. Gerard K, Dobson M, Hall J: Framing and labelling effects in health descriptions: quality adjusted life years for treatment of breast cancer. J Clin Epidemiol 46:77-84, 1993
11. Slevin ML, Stubbs L, Plant HJ, et al: Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and the general public. Br Med J 300:1458-1460, 1990
12. Simes RJ, Cocker K, Glasziou P, et al: Costs and benefits of adjuvant chemotherapy for breast cancer: An assessment of patient preferences. Proc Am Soc Clin Oncol 8:52A, 1989 (abstr)
13. Schipper H, Clinch J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. J Clin Oncol 2:472-473, 1984
14. McCorkle R, Young K: Development of a symptom distress scale. Cancer Nurs 1:373-378, 1978
15. McHorney CA, Ware JE, Lu R, et al: The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40-66, 1994
16. Kornblith AB, Anderson J, Cella DF, et al: Quality of life assessment in hodgkin's disease survivors: A model for cooperative clinical trials. Oncology 4:93-101, 1990
17. Winer E, Lindley C, Hardee M, et al: Quality of life assessment in patients with breast cancer surviving 12 months or more following high dose chemotherapy with autologous bone marrow transplant. Proc Am Soc Clin Oncol 11:1328, 1992 (abstr)
18. Lindley CM, Hirsch JD, O'Neill CV, et al: Quality of life consequences of chemotherapy-induced emesis. Qual Life Res 1:331-340, 1992
19. Craig TJ, Comstock GW, Geiser PB: The quality of survival in breast cancer: A case-control comparison. Cancer 33:1451-1457, 1974
20. Vinokur AD, Threatt BA, Caplan RD, et al: Physician and psychosocial functioning and adjustment to breast cancer. Cancer 63:394-405, 1989
21. Hurny C, Bernhard J, Coates AS, et al: Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. Lancet 347:1279-1284, 1996
22. Lin PP, Allison DC, Wainstock J, et al: Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11:1536-1544, 1993
23. Gutman H, Kersz T, Barzilai T, et al: Achievement of physical therapy in patients after modified radical mastectomy compared with quadratectomy, axillary dissection, and radiation for carcinoma of the breast. Arch Surg 125:389-391, 1990
24. Larson D, Weinstein M, Goldberg I, et al: Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 12:1575-1582, 1986
25. Lerner R, Requena R: Upper extremity lymphedema secondary to mammary cancer treatment. Am J Clin Oncol 9:481-487, 1986
26. Lotze MT, Duncan MA, Gerber LH, et al: Early versus delayed shoulder motion following axillary dissection: A randomized prospective study. Ann Surg 193:288-295, 1981
27. Say CC, Donegan W: A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet 138:370-376, 1974
28. Schag CAC, Ganz PA, Polinsky ML, et al: Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 11:783-793, 1993
29. Ravdin PM, Siminott LA, Harvey JA: Survey of American women who have received adjuvant chemotherapy. Breast Cancer Res Treat 41:219, 1996 (abstr)
30. Ashby J, O'Hanlon M, Buxton MJ: The time trade-off technique: How do the valuations of breast cancer patients compare to those of other groups? Qual Life Res 3:257-265, 1994
31. Henderson IC: Adjuvant systemic therapy for early breast cancer. Cancer 74:401-409, 1994